D35.1

Clinical Causes: T h e e x a c t c a u s e o f b e n i g n t u m o r s i n t h e p a r a t h y r o i d g l a n d s i s n o t w e l l u n d e r s t o o d . F a c t o r s t h a t m a y c o n t r i b u t e i n c l u d e g e n e t i c p r e d i s p o s i t i o n s , c e r t a i n i n h e r i t e d s y n d r o m e s , o r u n e x p l a i n e d c e l l u l a r c h a n g e s . U n l i k e m a l i g n a n t t u m o r s , b e n i g n n e o p l a s m s d o n o t i n v a d e n e a r b y t i s s u e s o r m e t a s t a s i z e t o o t h e r p a r t s o f t h e b o d y .

Key Symptoms: Muscle weakness or fatigue Bone pain or fragility Frequent kidney stones Abdominal pain or nausea Constipation Nervousness or depression Increased thirst and urination Cognitive disturbances such as forgetfulness

Diagnosis Path: Blood tests to measure calcium and parathyroid hormone (PTH) levels, which are often elevated Urinalysis to check for excess calcium excretion Imaging studies like sestamibi scans, ultrasound, or MRI to locate the tumor Bone density scans to assess for bone loss related to the condition

Treatment Protocols: Surgical removal of the affected parathyroid gland(s), often performed through minimally invasive techniques Monitoring for small or asymptomatic tumors if intervention risks outweigh benefits Postoperative management to address any fluctuations in calcium levels, which may require supplements or medication